The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enterprise PACS Market Research Report 2025
Synopsis
Global Enterprise PACS market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enterprise PACS market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Enterprise PACS market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Agfa HealthCare
Carestream Health
Fujifilm Medical Systems
GE Healthcare
IBM Watson Health
Intelerad Medical Systems
McKesson Corporation
Philips Healthcare
Sectra AB
Siemens Healthineers
TeraRecon, Inc.
Infinitt Healthcare Co., Ltd.
Novarad Corporation
Visage Imaging, Inc.
Segment by Type
Radiology PACS
Cardiology PACS
Dermatology PACS
Oncology PACS
Segment by Application
Electronic Health Records (EHRS)
Secure Storage of Multiple Departments
Visualization of 2D and 3D Imaging
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Enterprise PACS report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Enterprise PACS market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enterprise PACS market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Enterprise PACS market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Agfa HealthCare
Carestream Health
Fujifilm Medical Systems
GE Healthcare
IBM Watson Health
Intelerad Medical Systems
McKesson Corporation
Philips Healthcare
Sectra AB
Siemens Healthineers
TeraRecon, Inc.
Infinitt Healthcare Co., Ltd.
Novarad Corporation
Visage Imaging, Inc.
Segment by Type
Radiology PACS
Cardiology PACS
Dermatology PACS
Oncology PACS
Segment by Application
Electronic Health Records (EHRS)
Secure Storage of Multiple Departments
Visualization of 2D and 3D Imaging
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Enterprise PACS report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enterprise PACS Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiology PACS
1.2.3 Cardiology PACS
1.2.4 Dermatology PACS
1.2.5 Oncology PACS
1.3 Market by Application
1.3.1 Global Enterprise PACS Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Electronic Health Records (EHRS)
1.3.3 Secure Storage of Multiple Departments
1.3.4 Visualization of 2D and 3D Imaging
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enterprise PACS Market Perspective (2018-2029)
2.2 Enterprise PACS Growth Trends by Region
2.2.1 Global Enterprise PACS Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Enterprise PACS Historic Market Size by Region (2018-2023)
2.2.3 Enterprise PACS Forecasted Market Size by Region (2024-2029)
2.3 Enterprise PACS Market Dynamics
2.3.1 Enterprise PACS Industry Trends
2.3.2 Enterprise PACS Market Drivers
2.3.3 Enterprise PACS Market Challenges
2.3.4 Enterprise PACS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enterprise PACS Players by Revenue
3.1.1 Global Top Enterprise PACS Players by Revenue (2018-2023)
3.1.2 Global Enterprise PACS Revenue Market Share by Players (2018-2023)
3.2 Global Enterprise PACS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Enterprise PACS Revenue
3.4 Global Enterprise PACS Market Concentration Ratio
3.4.1 Global Enterprise PACS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enterprise PACS Revenue in 2022
3.5 Enterprise PACS Key Players Head office and Area Served
3.6 Key Players Enterprise PACS Product Solution and Service
3.7 Date of Enter into Enterprise PACS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Enterprise PACS Breakdown Data by Type
4.1 Global Enterprise PACS Historic Market Size by Type (2018-2023)
4.2 Global Enterprise PACS Forecasted Market Size by Type (2024-2029)
5 Enterprise PACS Breakdown Data by Application
5.1 Global Enterprise PACS Historic Market Size by Application (2018-2023)
5.2 Global Enterprise PACS Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Enterprise PACS Market Size (2018-2029)
6.2 North America Enterprise PACS Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Enterprise PACS Market Size by Country (2018-2023)
6.4 North America Enterprise PACS Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enterprise PACS Market Size (2018-2029)
7.2 Europe Enterprise PACS Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Enterprise PACS Market Size by Country (2018-2023)
7.4 Europe Enterprise PACS Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enterprise PACS Market Size (2018-2029)
8.2 Asia-Pacific Enterprise PACS Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Enterprise PACS Market Size by Region (2018-2023)
8.4 Asia-Pacific Enterprise PACS Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enterprise PACS Market Size (2018-2029)
9.2 Latin America Enterprise PACS Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Enterprise PACS Market Size by Country (2018-2023)
9.4 Latin America Enterprise PACS Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enterprise PACS Market Size (2018-2029)
10.2 Middle East & Africa Enterprise PACS Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Enterprise PACS Market Size by Country (2018-2023)
10.4 Middle East & Africa Enterprise PACS Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agfa HealthCare
11.1.1 Agfa HealthCare Company Detail
11.1.2 Agfa HealthCare Business Overview
11.1.3 Agfa HealthCare Enterprise PACS Introduction
11.1.4 Agfa HealthCare Revenue in Enterprise PACS Business (2018-2023)
11.1.5 Agfa HealthCare Recent Development
11.2 Carestream Health
11.2.1 Carestream Health Company Detail
11.2.2 Carestream Health Business Overview
11.2.3 Carestream Health Enterprise PACS Introduction
11.2.4 Carestream Health Revenue in Enterprise PACS Business (2018-2023)
11.2.5 Carestream Health Recent Development
11.3 Fujifilm Medical Systems
11.3.1 Fujifilm Medical Systems Company Detail
11.3.2 Fujifilm Medical Systems Business Overview
11.3.3 Fujifilm Medical Systems Enterprise PACS Introduction
11.3.4 Fujifilm Medical Systems Revenue in Enterprise PACS Business (2018-2023)
11.3.5 Fujifilm Medical Systems Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Enterprise PACS Introduction
11.4.4 GE Healthcare Revenue in Enterprise PACS Business (2018-2023)
11.4.5 GE Healthcare Recent Development
11.5 IBM Watson Health
11.5.1 IBM Watson Health Company Detail
11.5.2 IBM Watson Health Business Overview
11.5.3 IBM Watson Health Enterprise PACS Introduction
11.5.4 IBM Watson Health Revenue in Enterprise PACS Business (2018-2023)
11.5.5 IBM Watson Health Recent Development
11.6 Intelerad Medical Systems
11.6.1 Intelerad Medical Systems Company Detail
11.6.2 Intelerad Medical Systems Business Overview
11.6.3 Intelerad Medical Systems Enterprise PACS Introduction
11.6.4 Intelerad Medical Systems Revenue in Enterprise PACS Business (2018-2023)
11.6.5 Intelerad Medical Systems Recent Development
11.7 McKesson Corporation
11.7.1 McKesson Corporation Company Detail
11.7.2 McKesson Corporation Business Overview
11.7.3 McKesson Corporation Enterprise PACS Introduction
11.7.4 McKesson Corporation Revenue in Enterprise PACS Business (2018-2023)
11.7.5 McKesson Corporation Recent Development
11.8 Philips Healthcare
11.8.1 Philips Healthcare Company Detail
11.8.2 Philips Healthcare Business Overview
11.8.3 Philips Healthcare Enterprise PACS Introduction
11.8.4 Philips Healthcare Revenue in Enterprise PACS Business (2018-2023)
11.8.5 Philips Healthcare Recent Development
11.9 Sectra AB
11.9.1 Sectra AB Company Detail
11.9.2 Sectra AB Business Overview
11.9.3 Sectra AB Enterprise PACS Introduction
11.9.4 Sectra AB Revenue in Enterprise PACS Business (2018-2023)
11.9.5 Sectra AB Recent Development
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Detail
11.10.2 Siemens Healthineers Business Overview
11.10.3 Siemens Healthineers Enterprise PACS Introduction
11.10.4 Siemens Healthineers Revenue in Enterprise PACS Business (2018-2023)
11.10.5 Siemens Healthineers Recent Development
11.11 TeraRecon, Inc.
11.11.1 TeraRecon, Inc. Company Detail
11.11.2 TeraRecon, Inc. Business Overview
11.11.3 TeraRecon, Inc. Enterprise PACS Introduction
11.11.4 TeraRecon, Inc. Revenue in Enterprise PACS Business (2018-2023)
11.11.5 TeraRecon, Inc. Recent Development
11.12 Infinitt Healthcare Co., Ltd.
11.12.1 Infinitt Healthcare Co., Ltd. Company Detail
11.12.2 Infinitt Healthcare Co., Ltd. Business Overview
11.12.3 Infinitt Healthcare Co., Ltd. Enterprise PACS Introduction
11.12.4 Infinitt Healthcare Co., Ltd. Revenue in Enterprise PACS Business (2018-2023)
11.12.5 Infinitt Healthcare Co., Ltd. Recent Development
11.13 Novarad Corporation
11.13.1 Novarad Corporation Company Detail
11.13.2 Novarad Corporation Business Overview
11.13.3 Novarad Corporation Enterprise PACS Introduction
11.13.4 Novarad Corporation Revenue in Enterprise PACS Business (2018-2023)
11.13.5 Novarad Corporation Recent Development
11.14 Visage Imaging, Inc.
11.14.1 Visage Imaging, Inc. Company Detail
11.14.2 Visage Imaging, Inc. Business Overview
11.14.3 Visage Imaging, Inc. Enterprise PACS Introduction
11.14.4 Visage Imaging, Inc. Revenue in Enterprise PACS Business (2018-2023)
11.14.5 Visage Imaging, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
